WuXi Biologics block swells to HK$5bn on strong demand
WuXi Biologics Holdings, which listed in Hong Kong in June in a hugely popular IPO, raised HK$5.07bn ($649m) from a block trade that was increased in size on the back of strong investor demand.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: